Skip to content

Clinical trials

Phase 1 Diabetes Mellitus trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus Phase: Phase 1 Country / region: Germany Clear all

124 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20015
20021
20033
20043
20053
20068
20077
20083
200910
20109
20118
201210
201310
201417
20157
20166
20172
20185
20192
20221
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed118
Terminated2
Active, not recruiting1
Recruiting1
Suspended1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S99
Profil Institut für Stoffwechselforschung GmbH6
Gan and Lee Pharmaceuticals, USA3
Julphar Gulf Pharmaceutical Industries3
AstraZeneca2
Adocia1
Astellas Pharma Europe B.V.1
Beta-Stim Ltd.1
Eli Lilly and Company1
Genexine, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus124
Diabetes Mellitus, Type 141
Diabetes Mellitus, Type 241
Insulin Resistance4
Body Weight1
Endocrine System Diseases1
Glucose Metabolism Disorders1
Hypoglycemia1
Metabolic Diseases1
Nutrition Disorders1

Trials

Showing 1 to 25 of 124. Each trial links to its page on Pharma Observatory.

24 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.